期刊
MEDICINAL CHEMISTRY RESEARCH
卷 22, 期 4, 页码 1979-1997出版社
SPRINGER BIRKHAUSER
DOI: 10.1007/s00044-012-0204-x
关键词
beta-Secretase inhibitors; Transition state; Alzheimer's; Pharmacophore modeling; Quantitative structure-activity relationship
资金
- Hamdi-Mango Center for Scientific Research at the University of Jordan
Transition state analogues (TSA)-based inhibitors have particularly potent inhibitory profiles. The fact that beta-secretase (BACE) inhibitors have potential as anti-Alzheimer's treatments prompted us to explore the pharmacophoric space of 68 known TSA BACE inhibitors. Subsequently, quantitative structure-activity relationship (QSAR) analysis was employed to select optimal combination of binding model(s) and 2D physicochemical descriptors capable of explaining bioactivity variation. One pharmacophoric model emerged in the successful QSAR equation. However, to closely mimic the sterically demanding transition state of BACE we were obliged to complement the successful pharmacophore with strict shape-based query decorated with carefully positioned hydroxyl fragment that simulates the statin hydroxyl of known TSA BACE inhibitors. Both models, i.e., the hybrid shape-OH and optimal pharmacophore, were validated via receiver-operating characteristic curve analysis and were found to exhibit excellent abilities in discerning active compounds from decoys. Subsequent in silico screening against the National Cancer Institute structural database using the two models yielded two novel inhibitors of nanomolar and low micromolar IC50 values.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据